16218 Federal Register / Vol. 87, No. 55 / Tuesday, March 22, 2022 / Notices 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice entitled ‘‘Verification Systems 

Under the Drug Supply Chain Security 

Act for Certain Prescription Drugs; Draft 

Guidance for Industry’’ that appeared in 

the Federal Register of March 10, 2022. 

The document omitted the date by 

which comments on the draft guidance 

should be submitted to FDA. This error 

is corrected in this document for clarity. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Venti, Office of Compliance, 

Center for Drug Evaluation and 

Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Silver Spring, MD 20993–0002, 

301–796–3130, drugtrackandtrace@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of March 10, 2022 (87 

FR 13738), appearing on page 13738, in 

FR Doc. 2022–05018, in the second 

column, the DATES section is corrected 

to read as follows: 

DATES: The announcement of the 

guidance is published in the Federal 

Register on March 10, 2022. Although 

you can comment on any guidance at 

any time (see 21 CFR 10.115(g)(5)), to 

ensure that the Agency considers your 

comment on this draft guidance before 

it begins work on the final version of the 

guidance, submit either electronic or 

written comments on the draft guidance 

by May 9, 2022. 

Dated: March 17, 2022. 

Andi Lipstein Fristedt, 

Deputy Commissioner for Policy, Legislation, 

and International Affairs, U.S. Food and Drug 

Administration. 

[FR Doc. 2022–06006 Filed 3–21–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Diabetes and Digestive and Kidney 

Diseases Special Emphasis Panel, March 

23, 2022, 09:00 a.m. to March 24, 2022, 

04:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD, 20892 which was 

published in the Federal Register on 

February 25, 2022, 308582. 

Dr. Kozel wants to change the date for 

his meeting. The meeting is closed to 

the public. 

Dated: March 16, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05966 Filed 3–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Acquired Immunodeficiency 

Syndrome Research Study Section; Acquired 

Immunodeficiency Syndrome Research 

Study Section (AIDS). 

Date: April 20, 2022. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3F40A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Dimitrios Nikolaos 

Vatakis, Ph.D., Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, National Institute of 

Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, MSC– 

9823, Bethesda, MD 20892, (301) 761–7176, 

dimitrios.vatakis@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 16, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05968 Filed 3–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Sleep Disorders 

Research Advisory Board, April 7, 2022, 

12:00 p.m. to 5:00 p.m., Virtual Meeting, 

which was published in the Federal 

Register on March 09, 2022, V 87 Vol. 

46, Page 13302, FR Doc No. 2022– 

04982. 

Meeting is being amended to change 

the telephone call in number to 1–669– 

254–5252 (Meeting ID: 161 532 8417 

Passcode: 330488). The meeting is open 

to the public. 

Dated: March 16, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05969 Filed 3–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Clinical Trials and 

Comparative Effectiveness Studies in 

Neurology. 

Date: March 28–29, 2022. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shanta Rajaram, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 


lotter on DSK11XQN23PROD with NOTICES1